4//SEC Filing
Joshi Abhay 4
Accession 0001479290-21-000043
CIK 0001479290other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:10 PM ET
Size
7.0 KB
Accession
0001479290-21-000043
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2021-02-15$28.97/sh−1,967$56,984→ 132,603 total - Tax Payment
Common Stock
2021-02-15$28.97/sh−2,881$83,463→ 129,722 total
Footnotes (3)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2021, to satisfy tax withholding obligations that arose in connection with the vesting of the Restricted Stock award ("RSA") for 15,750 shares. The RSA vests in three equal annual installments from February 15, 2019, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The fair market value was determined on February 12, 2021 pursuant to the Plan.
- [F3]Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2021, to satisfy tax withholding obligations that arose in connection with the vesting of the RSA for 25,000 shares. The RSA vests in three equal annual installments from February 15, 2020, subject to Dr. Joshi's Continuous Service (as defined in the Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001359089
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:10 PM ET
- Size
- 7.0 KB